183 related articles for article (PubMed ID: 20304979)
1. Defective nucleolar localization and dominant interfering properties of a parafibromin L95P missense mutant causing the hyperparathyroidism-jaw tumor syndrome.
Panicker LM; Zhang JH; Dagur PK; Gastinger MJ; Simonds WF
Endocr Relat Cancer; 2010 Jun; 17(2):513-24. PubMed ID: 20304979
[TBL] [Abstract][Full Text] [Related]
2. Nuclear localization of the parafibromin tumor suppressor protein implicated in the hyperparathyroidism-jaw tumor syndrome enhances its proapoptotic function.
Lin L; Czapiga M; Nini L; Zhang JH; Simonds WF
Mol Cancer Res; 2007 Feb; 5(2):183-93. PubMed ID: 17314275
[TBL] [Abstract][Full Text] [Related]
3. Characterization of a new CDC73 missense mutation that impairs Parafibromin expression and nucleolar localization.
Masi G; Iacobone M; Sinigaglia A; Mantelli B; Pennelli G; Castagliuolo I; Palù G; Barzon L
PLoS One; 2014; 9(5):e97994. PubMed ID: 24842573
[TBL] [Abstract][Full Text] [Related]
4. HRPT2, a tumor suppressor gene for hyperparathyroidism-jaw tumor syndrome.
Wang PF; Tan MH; Zhang C; Morreau H; Teh BT
Horm Metab Res; 2005 Jun; 37(6):380-3. PubMed ID: 16001331
[TBL] [Abstract][Full Text] [Related]
5. Characterization of a novel CDC73 gene mutation in a hyperparathyrodism-jaw tumor patient affected by parathyroid carcinoma in the absence of somatic loss of heterozygosity.
Ciuffi S; Cianferotti L; Nesi G; Luzi E; Marini F; Giusti F; Zonefrati R; Gronchi G; Perigli G; Brandi ML
Endocr J; 2019 Apr; 66(4):319-327. PubMed ID: 30799315
[TBL] [Abstract][Full Text] [Related]
6. Parafibromin mutations in hereditary hyperparathyroidism syndromes and parathyroid tumours.
Bradley KJ; Cavaco BM; Bowl MR; Harding B; Cranston T; Fratter C; Besser GM; Conceição Pereira M; Davie MW; Dudley N; Leite V; Sadler GP; Seller A; Thakker RV
Clin Endocrinol (Oxf); 2006 Mar; 64(3):299-306. PubMed ID: 16487440
[TBL] [Abstract][Full Text] [Related]
7. Tumor suppressor gene mutation in a patient with a history of hyperparathyroidism-jaw tumor syndrome and healed generalized osteitis fibrosa cystica: a case report and genetic pathophysiology review.
Parfitt J; Harris M; Wright JM; Kalamchi S
J Oral Maxillofac Surg; 2015 Jan; 73(1):194.e1-9. PubMed ID: 25511968
[TBL] [Abstract][Full Text] [Related]
8. Analysis of aberrantly spliced HRPT2 transcripts and the resulting proteins in HPT-JT syndrome.
Moon S; Kim JH; Shim JY; Ahn YB; Song KH; Cha BY; Maeng LS; Han JH
Mol Genet Metab; 2010 Aug; 100(4):365-71. PubMed ID: 20541447
[TBL] [Abstract][Full Text] [Related]
9. Crystal structure of the N-terminal domain of human CDC73 and its implications for the hyperparathyroidism-jaw tumor (HPT-JT) syndrome.
Sun W; Kuang XL; Liu YP; Tian LF; Yan XX; Xu W
Sci Rep; 2017 Nov; 7(1):15638. PubMed ID: 29142233
[TBL] [Abstract][Full Text] [Related]
10. Parafibromin, product of the hyperparathyroidism-jaw tumor syndrome gene HRPT2, regulates cyclin D1/PRAD1 expression.
Woodard GE; Lin L; Zhang JH; Agarwal SK; Marx SJ; Simonds WF
Oncogene; 2005 Feb; 24(7):1272-6. PubMed ID: 15580289
[TBL] [Abstract][Full Text] [Related]
11. Mice deleted for cell division cycle 73 gene develop parathyroid and uterine tumours: model for the hyperparathyroidism-jaw tumour syndrome.
Walls GV; Stevenson M; Lines KE; Newey PJ; Reed AAC; Bowl MR; Jeyabalan J; Harding B; Bradley KJ; Manek S; Chen J; Wang P; Williams BO; Teh BT; Thakker RV
Oncogene; 2017 Jul; 36(28):4025-4036. PubMed ID: 28288139
[TBL] [Abstract][Full Text] [Related]
12. Cell division cycle protein 73 homolog (CDC73) mutations in the hyperparathyroidism-jaw tumor syndrome (HPT-JT) and parathyroid tumors.
Newey PJ; Bowl MR; Cranston T; Thakker RV
Hum Mutat; 2010 Mar; 31(3):295-307. PubMed ID: 20052758
[TBL] [Abstract][Full Text] [Related]
13. Large intragenic deletion of CDC73 (exons 4-10) in a three-generation hyperparathyroidism-jaw tumor (HPT-JT) syndrome family.
Guarnieri V; Seaberg RM; Kelly C; Jean Davidson M; Raphael S; Shuen AY; Baorda F; Palumbo O; Scillitani A; Hendy GN; Cole DEC
BMC Med Genet; 2017 Aug; 18(1):83. PubMed ID: 28774260
[TBL] [Abstract][Full Text] [Related]
14. A novel CDC73 gene mutation in an Italian family with hyperparathyroidism-jaw tumour (HPT-JT) syndrome.
Chiofalo MG; Sparaneo A; Chetta M; Franco R; Baorda F; Cinque L; Granatiero M; D'Agruma L; Pezzullo L; Scillitani A; Guarnieri V
Cell Oncol (Dordr); 2014 Aug; 37(4):281-8. PubMed ID: 25113791
[TBL] [Abstract][Full Text] [Related]
15. Loss of nuclear expression of parafibromin distinguishes parathyroid carcinomas and hyperparathyroidism-jaw tumor (HPT-JT) syndrome-related adenomas from sporadic parathyroid adenomas and hyperplasias.
Gill AJ; Clarkson A; Gimm O; Keil J; Dralle H; Howell VM; Marsh DJ
Am J Surg Pathol; 2006 Sep; 30(9):1140-9. PubMed ID: 16931959
[TBL] [Abstract][Full Text] [Related]
16. Parafibromin-deficient (HPT-JT Type, CDC73 Mutated) Parathyroid Tumors Demonstrate Distinctive Morphologic Features.
Gill AJ; Lim G; Cheung VKY; Andrici J; Perry-Keene JL; Paik J; Sioson L; Clarkson A; Sheen A; Luxford C; Elston MS; Meyer-Rochow GY; Nano MT; Kruijff S; Engelsman AF; Sywak M; Sidhu SB; Delbridge LW; Robinson BG; Marsh DJ; Toon CW; Chou A; Clifton-Bligh RJ
Am J Surg Pathol; 2019 Jan; 43(1):35-46. PubMed ID: 29324469
[TBL] [Abstract][Full Text] [Related]
17. A Novel Mutation in a Patient with Hyperparathyroidism-Jaw Tumour Syndrome.
Bellido V; Larrañaga I; Guimón M; Martinez-Conde R; Eguia A; Perez de Nanclares G; Castaño L; Gaztambide S
Endocr Pathol; 2016 Jun; 27(2):142-6. PubMed ID: 26995009
[TBL] [Abstract][Full Text] [Related]
18. Identification of a functional bipartite nuclear localization signal in the tumor suppressor parafibromin.
Hahn MA; Marsh DJ
Oncogene; 2005 Sep; 24(41):6241-8. PubMed ID: 16116486
[TBL] [Abstract][Full Text] [Related]
19. Identification and functional characterization of three NoLS (nucleolar localisation signals) mutations of the CDC73 gene.
Pazienza V; la Torre A; Baorda F; Alfarano M; Chetta M; Muscarella LA; Battista C; Copetti M; Kotzot D; Kapelari K; Al-Abdulrazzaq D; Perlman K; Sochett E; Cole DE; Pellegrini F; Canaff L; Hendy GN; D'Agruma L; Zelante L; Carella M; Scillitani A; Guarnieri V
PLoS One; 2013; 8(12):e82292. PubMed ID: 24340015
[TBL] [Abstract][Full Text] [Related]
20. Hyperparathyroidism-jaw tumor syndrome in Roma families from Portugal is due to a founder mutation of the HRPT2 gene.
Cavaco BM; Guerra L; Bradley KJ; Carvalho D; Harding B; Oliveira A; Santos MA; Sobrinho LG; Thakker RV; Leite V
J Clin Endocrinol Metab; 2004 Apr; 89(4):1747-52. PubMed ID: 15070940
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
